Nu Skin Enterprises (NUS) Misses Q4 EPS by 1c; Reiterates Outlook
Get Alerts NUS Hot Sheet
Price: $4.84 +2.98%
Revenue Growth %: +3.1%
Financial Fact:
Diluted (in shares): 57.85M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +3.1%
Financial Fact:
Diluted (in shares): 57.85M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Nu Skin Enterprises (NYSE: NUS) reported Q4 EPS of $0.79, $0.01 worse than the analyst estimate of $0.80. Revenue for the quarter came in at $531.3 million versus the consensus estimate of $553.19 million.
The company also reiterated guidance provided at its 2016 investor day in December with anticipated revenue of $2.26 to $2.30 billion and earnings per share of $3.10 to $3.25, assuming a 3 to 4 percent negative foreign currency impact.
For earnings history and earnings-related data on Nu Skin Enterprises (NUS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- Guidewire Software (GWRE) Tops Q4 EPS by 6c; Offers Guidance
- John Wiley & Sons, Inc. (WLYB) Misses Q1 EPS by 2c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share